| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f541d256b6b35effe788f0a8cf8269b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc7596f63800cafa0c70266fdb4480cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate |
2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_278e5737cd9d9825b346c3ca8472f908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c71bb714d67006f88c9e45d04cf2a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc2d065262b07737b7d943da7f4ee145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2587b6396372bf3d4cbd19dde45dd36a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec29c7b8908329a5fbecec267500cb6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f532d294464645d59cbb84a51bc3459
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3b1f8a014c631649656ef19fa63ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29933a296649e4f14ec815c3c7b21f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d6c77d6befe0090db978b003cb3509 |
| publicationDate |
2022-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4106870-A1 |
| titleOfInvention |
Compositions and therapeutic uses of cannabidiol |
| abstract |
The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine. |
| priorityDate |
2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |